Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |